Search Results
Aug 03, 2026, 10:30 ET Tumor Ablation Market worth $1.89 billion by 2031 - Exclusive Report by MarketsandMarkets™
approaches. While traditional revenue has been driven by established ablation technologies such as radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, high-intensity focused ultrasound (HIFU), and consumables, future growth is expected to be fueled by next-generation innovations including
More news about: MarketsandMarkets
Jun 29, 2026, 08:30 ET Baird Medical Announces First Microwave Ablation Procedures Using Its Technology in Vietnam and Argentina
BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful completion of the first procedures using its MWA technology in Vietnam and Argentina.
More news about: BDMD
Jun 09, 2026, 08:30 ET Baird Medical Establishes Global Headquarters in New York City, Reinforcing Commitment to U.S. Commercial Expansion
Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the relocation of its global headquarters to the U.S., with the establishment of a new corporate office in New York,
More news about: BDMD
Apr 29, 2026, 08:30 ET Baird Medical Reports Full Year 2025 Financial Results and Provides Corporate Update
Company's microwave ablation (MWA) devices, partially offset by growth in other regions.Revenue from direct customers decreased from $19.8 million in 2024 to $4.1 million in 2025, primarily due to lower sales volume and reduced selling prices in Mainland China. Sales of MWA needles declined due to
More news about: BDMD
Mar 16, 2026, 08:30 ET Baird Medical Advances Clinical Education with Expert-Led Workshops in Indonesia
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful execution of two clinical training workshops in Indonesia. This initiative supports the Company's strategic
More news about: BDMD
Mar 12, 2026, 08:30 ET Baird Medical Expands Global Reach with Regulatory Clearance in Argentina
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the regulatory clearance of its systems in Argentina. This milestone drives the Company's international growth, supporting
More news about: BDMD
Mar 09, 2026, 08:30 ET Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology at NASIT 2026
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successful strategic showcase at the 2026 North American Society for Interventional Thyroidology (NASIT) in Portland,
More news about: BDMD
Mar 04, 2026, 08:30 ET Baird Medical Accelerates Global Registration of AI-Driven Surgical Software
2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful completion of development for its cross-platform surgical software, officially commencing the registration
More news about: BDMD
Mar 02, 2026, 08:30 ET Baird Medical Accelerates U.S. Expansion at NASOIE 2026
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation at the 2026 North American Society of Interventional Endocrinologists (NASOIE) Annual Meeting in Miami,
More news about: BDMD
Feb 25, 2026, 08:30 ET Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across the United States. This momentum directly supports the Company's strategy to accelerate global
More news about: BDMD
Feb 19, 2026, 08:30 ET Baird Medical to Showcase Minimally Invasive Thyroid Solutions at Upcoming US Clinical Conferences
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation for three major clinical conferences this quarter. These events are pivotal to the company's expansion,
More news about: BDMD
Feb 11, 2026, 08:30 ET Baird Medical Drives U.S. Market Penetration with Commercial Launch at Bakersfield Memorial Hospital
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the strategic commercial deployment of its technology at Bakersfield Memorial Hospital in California. This launch represents
More news about: BDMD
Feb 09, 2026, 08:30 ET Baird Medical Accelerates Global Commercial Roadmap with Strategic Clinical Education Initiatives in the U.S. and Japan
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the execution of premier clinical education programs in the United States and Japan. These strategic engagements reinforce
More news about: BDMD
Jan 28, 2026, 08:30 ET Baird Medical Successfully Concludes Gynecology Microwave Ablation Masterclass
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful conclusion of its Gynecological Microwave Ablation Masterclass in Shanghai. Led by Dr. Xiaoming Gong of Weheal,
More news about: BDMD
Jan 26, 2026, 08:30 ET Baird Medical Accelerates Global Commercial Roadmap through Strategic Partnership with Stonewood Key Capital
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced a strategic partnership with Stonewood Key Capital, a wholly-owned comprehensive investment management enterprise from New
More news about: BDMD
Jan 20, 2026, 08:30 ET Baird Medical Highlights Strategic Engagement at 2026 J.P. Morgan Healthcare Conference
-- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successful participation in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco.
More news about: BDMD
Jan 07, 2026, 21:56 ET STARMED Unveils New Brand Identity to Drive Global Multi-Modality Strategy
system. The current rebranding signals a strategic commitment to expand beyond RFA by integrating diverse energy sources, including Microwave Ablation (MWA) and Irreversible Electroporation (IRE), into a unified therapeutic offering."With the global thermal ablation market projected to reach $2 billion
More news about: STARMED
Jan 07, 2026, 21:39 ET STARMED Unveils New Brand Identity to Drive Global Multi-Modality Strategy
system. The current rebranding signals a strategic commitment to expand beyond RFA by integrating diverse energy sources, including Microwave Ablation (MWA) and Irreversible Electroporation (IRE), into a unified therapeutic offering."With the global thermal ablation market projected to reach $2 billion
More news about: STARMED
Jan 07, 2026, 08:30 ET Baird Medical Secures Regulatory Approvals in Pakistan and Vietnam
2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in Microwave Ablation (MWA) technology, today announced it has reached key regulatory milestones with official product registrations from both the Medical Device Board (MDB) of
More news about: BDMD
Dec 17, 2025, 08:30 ET Baird Medical Establishes U.S. Manufacturing Base to Accelerate Global Expansion and Future R&D
2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in Microwave Ablation (MWA) technology, today announced the establishment of a dedicated manufacturing base in the United States. This development marks a pivotal step in Baird
More news about: BDMD
Dec 08, 2025, 08:30 ET Baird-Sponsored Microwave Ablation Training Enhances Thyroid Treatment Capabilities for Leading Arizona Surgeon
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in Microwave Ablation (MWA) technology, recently concluded an advanced MWA training session in New Orleans. This initiative reinforces the Company's commitment to accelerating the adoption of minimally
More news about: BDMD
Dec 03, 2025, 08:30 ET Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the appointment of Mark Saxton as Chief Executive Officer of its U.S. subsidiary.
More news about: BDMD
Nov 11, 2025, 12:30 ET Interventional Oncology Market to Reach $4.38 Billion by 2030 at CAGR 8.55% - Grand View Research, Inc.
rapid expansion is driven by the increasing adoption of minimally invasive techniques, such as Radiofrequency Ablation (RFA) and Microwave Ablation (MWA). These methods offer precise tumor destruction as alternatives to surgery. Based on application, the liver cancer segment
More news about: Grand View Research, Inc
Nov 03, 2025, 08:30 ET Baird Medical Enters Egyptian Market with First Successful Bone Tumor Ablation
was found to have a 1 x 1.5 cm bone lesion. The MWA procedure was completed safely and effectively, achieving full ablation and providing the patient with significant pain relief. This case highlights the versatility of the Baird MWA system, demonstrating its capabilities beyond
More news about: BDMD
Oct 27, 2025, 08:30 ET Baird Medical's MWA System Achieves Successful Medicare Reimbursement at Prominent New York Practice
/PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced the clinical adoption of its MWA system at Elk Medical, a prominent private endocrinology practice in Brooklyn, New York.
More news about: BDMD